Valuation Jade Biosciences, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 17/09/2026 +04			5-day change	1st Jan Change
16.65 ^USD	-4.20%		-12.64%	+7.91%

09-09	Jade Biosciences, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 09:20 AM
09-04	Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	709.8	1,059	-	-
Change	-	49.17%	-	-
Enterprise Value (EV) ¹	373.7	713.2	705.2	723
Change	-	90.86%	-1.13%	2.53%
P/E	-4.84x	-5.7x	-5.8x	-5.85x
PBR	-	3.88x	8.31x	4.62x
PEG	-0.2x	0.67x	3.32x	6.81x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-3.18x	-3.04x	-3.01x
EV / EBIT	-3.29x	-3.35x	-2.98x	-2.76x
EV / FCF	-3.94x	-4.16x	-3.01x	-2.86x
FCF Yield	-25.4%	-24%	-33.2%	-34.9%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-3.19	-2.92	-2.869	-2.845
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	-
EBITDA ¹	-	-224.4	-232.3	-240.4
EBIT ¹	-113.5	-212.7	-236.8	-261.7
Net income ¹	-127.4	-204.2	-231.1	-258.9
Net Debt ¹	-336.2	-345.7	-353.7	-335.9
Reference price ²	15.43	16.65	16.65	16.65
Nbr of stocks (in thousands)	46,004	63,597	-	-
Announcement Date	06/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
JADE BIOSCIENCES, INC.	-5.95x	-	-3.38x	-	1.11B
LONZA GROUP AG	31.39x	5.65x	16.94x	1.03%	45.81B
REVOLUTION MEDICINES, INC.	-20.96x	242.19x	-22.49x	-.--%	43.91B
IQVIA HOLDINGS INC.	34.73x	3.34x	14.43x	-.--%	44.39B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	26.93x	8.12x	20.58x	0.42%	31.26B
MEDPACE HOLDINGS, INC.	35.28x	5.79x	26.31x	-.--%	17.32B
EUROFINS SCIENTIFIC SE	24.5x	2.13x	9.21x	1.09%	14.73B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	73x	3.87x	15.01x	-.--%	13.03B
Average	27.15x	34.54x	11.69x	0.32%	27.88B
Weighted average by Cap.	26.32x	46.77x	11.89x	0.31%